FDA asks the Ophthalmic Devices Panel to discuss safety and other issues related to the Balance Ophthalmics FSYX ocular pump to lower intraocular pres...
FDA reports the key themes that emerged from a 3/2023 virtual meeting with patients and caregivers on long Covid.
CDER Office of Prescription Drug Promotion research demonstrates that consumers may be confused and conflate product benefits and risks when exposed t...
FDA solicits applications for grants to explore the role of digital health technologies in evaluating new drugs.
FDA proposes to evaluate drugs and categories of drugs that present demonstrable difficulties for compounding and place three categories on the lists.
Two U.S. House lawmakers introduce a bipartisan bill to create an emergency supply of active pharmaceutical ingredients (APIs) used in essential gener...
Federal Register notice: FDA withdraws approval of an Air Products and Chemicals NDA and new animal drug application for medical gas helium because th...
FDA publishes a guidance to assist in the design and analysis of studies assessing the influence of impaired renal function on an investigational drug...
